Added something new to the portfolio today $CTLT and

This is not a solicitation to buy, nor is it investment advice!

WKN US1488061029

Company Name: Catalent Inc

https://investor.catalent.com/financial-news/default.aspx

Founded in 2007; went public in 2014

Country: USA

Employees: 19,000

Investment type: medium-term to long-term

Industry: Healthcare

Dividend: None

Current P/E ratio: 27.45

Revenue 2019: 2.51 billion USD

Revenue 2020: 3.09 billion USD

Revenue 2021: 3.99 billion USD

Revenue 2022: 4.82 billion USD

2023 Revenue Forecast: up to 4.87 billion USD (Note that the reporting segments effective July 1, 2022, began for Q1/2023)

A global leader that enables partners in the pharmaceutical, biotechnology, and consumer health sectors to optimize the development, launch, and delivery of better patient treatments across multiple modalities.

A 2,800-square-meter expansion was recently completed in China’s Waigaoqiao Free Trade Zone (FTZ).

Through its flexible manufacturing platforms at over 50 locations worldwide, the company delivers approximately 80 billion doses of nearly 8,000 products annually.

What do you think of $XAIR ?

P.S. Looking for followers 😊

Michael H.@justoxford

3Año

Profitable they are yes

•

Mikel Nuts@Okra

@justoxford currently favorable entry, always looking for estimates 😊 have you already had contact with the other values in the direction of the future?

••

@Okra I have my doubts about both values. The information I see doesn't give me much courage. The question is always how much do I invest and what is the associated potential. Neither stock would be a buy for me.